Investment Forum
Home > Investment Forum
  • Introduction
  • Organization
  • Innovation For You
  • Join us

      Investment Forum, China Innovation in Cardiology(hereinafter referred to as the Forum) was co-founded on June 18, 2017 by the First Affiliated Hospital with Nanjing Medical University(Jiangsu Province Hospital), Dinova Capital, China Dinghui Investments, Huatai Medical Industry Investment Fund, CITIC Securities, CBridge Capital, OrbiMed, Morningside Venture Capital, SAIF Partners, BioVenture, Warbug Pincus with the aim to push forward the scientific research innovation of clinical medicine technologies and its translational applications, to establish a channel for the evaluation of professional projects and its investment and financing, and to build a favorable environment for the industrialization of innovative medical technologies, thus providing one-stop service for medical innovation. Supported by China Innovations in Cardiology(CIC),the Forum is engaged in building a platform for top investors, doctors, entrepreneurs and policy makers, through which they can work together to accomplish a translational process from concept to product by setting up an innovation company.


    Chairman:Professor Kong Xiangqing

    Executive Chairman: Michael Zhao

    Experts Consultancy Group

    Clinical Academic Experts Committee: Academician Gao Runlin, Professor Huo Yong, Professor Zhang Shu, Professor Ge Junbo, Professor Huang Congxin, Professor Horst Sievert, Professor MartinLeon, Professor Chaim Lotan, etc.

    Medical Engineering Conversion Experts Committee: Academician Zhang Xingdong, Professor Wang Yunbing, Chairman Jiang Feng, Xi Yanpei, Li Wei, Yao Chen, Jia Jianxiong, Professor Zheng Yufeng, Dr Dong Xinyuan, Dr Liu Dawei, etc.

    Drector-general: Dinova Capital

    Vice Drector-generalCDH Investments, Huatai Ruihe Healthcare Found

    Managing Director:

    CITIC Securities, Huatai Medical Industry Investment Fund, CBridge Capital, Orbi Med, Morning side Ventures, Warbug Pincus, SAIF Parters, Bio Venture.

    MemberThe institutional investor and start-up companies that will join in the future. 


    On 20th September, the first roadshow of “Innovation For You” has been successfully held as scheduled. It  is launched by Investment Forum of China Innovation in Cardiology(shorten as Forum)  and was  proceeding simultaneously in USA, Shanghai and Nanjing. About a hundred of people from more than 30 domestic investment institutions have been attracted to this roadshow.

    Five quality projects from California, Florida, Arizona, San Antonio in USA and Nanjing, China were invited to be present, covering such diversified areas as surgical instruments for thoracic surgery department, orthopedic biomaterial, bone prosthetic device, protective device in heart surgery and drugs screening platform. The roadshow was chaired by Mr. Qingchao Liu, the Vice President of Hautai Medical Industry Investment Fund (shorten as Hautai),  vice-council of the Forum. More than 30 renowned investment organizations and financing institutions including  Dinova Capital, Hautai, CITIC Securities, C-Bridge Capital, OrbiMed Advisors, Bio Venture, SAIF Partners, Morningside Venture Capital have participated in the business matching.

    This roadshow invited three chief physicians from Orthopedics department, Cardiology Department and Cardiac Surgery Department of Jiangsu Province Hospital, giving one-on-one in-depth comments and technology consultations on projects and offering detailed medical supports for subsequent investment decisions.

    The Forum will continue to launch various activities and build a platform for clinical experts, policy makers and industry investors to make close communication and cooperation.

    Any  inquiries and intended discussions from investment institutions are greatly welcome.

    Tel: 021-33537002*8032

    The Introduction of Roadshow’s Projects:                                      

     1. Miret: Minor instrument used in minimally invasive thoracic surgery

    Miret is an instrument used in Minilap(Mini endoscopic) surgery. It improves the surgery with standard endoscopic and makes Minilap surgery more easier. 

    2. Aperion : Orthopedic biomaterial 

    Z-Lig®ACL ReplacementZ-Fix®Z-Patch® , innovatively developed by Aperion, is a heterogenous ligament repair material applied to ligament reconstruction surgeries for  anterior cruciate ligament of the knee joint, shoulder and ankle ligaments,  Achilles's tendon and so on.

    3. Ancora: Cardiac valve annulus fixing device


    AccuCinch, developed by Ancora, creates a novel technology for stenosing mitral annulus .

    4. PONTiS: Innovative repairing device for tendon and bone


    PONTiS is a unique metallic material applied in the surgery of  suture between tendons, tendon-bone and tiny bones. PONTiS stitching wire has the advantages of high strength, low ductility and relatively low stimulation to tissues. It’s high strength will benefit the  function of joints during early rehabilitation.


    5.Help Stem Cell Innovation: Platform for Regenerative Heart Drug Screening Based on Human iPSC

    It provides a platform for screening new drugs for heart diseases and stem cell therapy. Compared with the current similar type of platforms, the qualities of iPSC are  more correspond with physiological characteristics of adult heart and will be better applied.


    For  detailed projects’ slides and doctors’ comments, please follow our official WeChat  account and send “920 roadshow information” in chat window. Our service staff will contact with you.

    Innovation requires not only the brave but the wise. Only through the joint efforts of academic and industrial circles can we break existing shackles and usher in a new era. We are convinced that, through our united efforts, the Forum will eventually become a benchmark in cardiovascular innovation field, offering all-round support to more and more innovative enterprises. The Forum will constantly place conducting concrete affairs and improving efficiency as top priority and complete the “last kilometer” of innovation.
    Any  inquiries and intended discussions are greatly welcome.
Past meetings Wall To WallMore>
        December 2, 2013, for the first time Wall To Wall conferences held in Tel Aviv, Israel, China symposium held during the same period ICI meeting, the Chairman of China Heart Medical Association, Peking University First Hospital, Professor and Chairman of the seminar Bennis Huo Yong, Israel Sa Luoka medical Center and professor of Sakha cardiovascular medicine to more than 100 experts, professors, medical enterprises to invest in people attended the seminar. At the meeting, experts from both countries to understand the impact of emerging technologies on current and future therapies from live case demonstration, from international experts to speak on important clinical problem in learning to focus and get information about future prospects insights and discuss bilateral treatment of different stages of development and the future of new therapies. Chinese Ambassador to Israel Miss Gao Yanping invited to attend the seminar, and Wall To Wall spoke highly of the project and the message to the two medical experts and medical organizations to cooperate in good faith, to share the advantages and achieved a win-win success.